Despite COVID, revenues for half of top 20 pharma companies grew 10-40% in
2021
Revenues (billions)
1 J&J $97
2 Pfizer $81
3 Roche $62
4 Abbvie $56
5 Novartis $51
6 Merck $48
7 BMS $46
8 GSK $46
9 Sanofi $44
10 AZ $37
https://t.co/rSovxIXOId https://t.co/GuKIBYoML6
Links:
Apr-14-2022


